title: Why not start with thalidomide?
authors.affiliation: Division of Medical Oncology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. cloprinzi@mayo.edu
authors.forename: Charles
authors.initials: C
authors.lastname: Loprinzi
authors.forename: S Vincent
authors.initials: SV
authors.lastname: Rajkumar
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D003657:Decision Making; D004992:Ethics, Medical; D005260:Female; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D013792:Thalidomide / Q000627:therapeutic use*; D014481:United States
chemical_list: D020533:Angiogenesis Inhibitors; D013792:Thalidomide